Leveraging Wearable Technologies for Arrhythmia Detection in Children - The PAW (Pediatric Apple Watch) Study
Sponsor: Stanford University
Trial Details
| Condition | Arrhythmia in Children |
| Intervention | Apple Watch |
| Phase | NA |
| Status | Completed |
| Participants | 107 |
| Est. Completion | 10 Jan 2026 |
| Last Updated | 15 July 2026 |
Primary Outcome
Heart rate correlation; Arrhythmia correlation
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * All pediatric patients age 6 - 21 years undergoing clinically indicated arrhythmia monitoring * Patients with developmental ability (as determined by patient and parents) to safely wear the Apple Watch and utilize the patient activated trigger buttons on both the clinical monitor and the Apple Watch. Exclusion Criteria: * Age \< 6 years. Those under 6 many not be able to safely use the watch and have the developmental ability (as gauged by clinician and parents) to utilize the trigger features on the watch and cardiac rhythm monitor. * Inability to effectively utilize the triggered features of the monitor or watch * Patients unable to utilize the Apple Watch.
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service